VCAM1 and cancer: Alternatively, macrophagemembrane-based biomimetic nanoparticles are widely used to expressintegrins (e.g., α4) on the surface of their membranes, enablingbinding to vascular cell adhesion molecule-1 (VCAM-1) on the surfaceof cancer cells.